Racial disparities in prostate cancer a molecular perspective
- 1 January 2017
- journal article
- review article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 22 (5), 772-782
- https://doi.org/10.2741/4515
Abstract
Prostate cancer incidence and mortality rates are remarkably higher in African-American men as compared to their European-Americans counterparts. Despite these recognitions, precise causes underlying such prevalent racial disparities remain poorly understood. Although socioeconomic factors could account for such differences up to a certain extent, it is now being increasingly realized that such disparity has a molecular basis. Indeed, several differences, including genetic polymorphism, gene mutations, epigenetic modifications, miRNAs alterations, etc., have been reported in malignant prostate tissues from patients of diverse racial backgrounds. Here, we attempt to provide a molecular perspective on prostate cancer racial disparities by gathering available information on these associated factors and discussing their potential significance in disproportionate incidence and clinical outcomes.Keywords
This publication has 63 references indexed in Scilit:
- Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activationOncotarget, 2015
- Chronic Inflammation and Cytokines in the Tumor MicroenvironmentJournal of Immunology Research, 2014
- Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American MenInternational Journal of Molecular Sciences, 2013
- Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate CancerScientifica, 2012
- Population differences in proinflammatory biology: Japanese have healthier profiles than AmericansBrain, Behavior, and Immunity, 2011
- Multiple loci identified in a genome-wide association study of prostate cancerNature Genetics, 2008
- The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men’s Health StudyJournal of Human Genetics, 2008
- Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.2000
- Clinical Characteristics and Biopsy Specimen Features in African-American and White Men Without Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrolCarcinogenesis: Integrative Cancer Research, 1995